Mountain Valley MD (CSE: MVMD- OTCQB: MVMDF) CEO Dennis Hancock joined Steve Darling to share news the company has announced it is commencing husbandry animal trials in Bangladesh. Those trials are to validate the commercial pathway for the Company’s injectable solubilized Ivermectin technology, Ivectosol 1%.
Hancock telling Proactive how big this step is for the company and also how Bangladesh will serve as a production hub for broader global distribution.